EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics

Yidan Zhu iD, Jinxia Zhao, Jiali Chen, Yiru Gong, Nan Guo, Yinyu Zhao, Yuanyuan Li, Jialu Bian, Xuchen Song, Yuxuan Yao, Xingxian Luo, Xiaohong Zhang und 1 weitere

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01169-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Yidan Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Voriconazole, Antifungal Agents. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is limited evidence on the recommended voriconazole (VCZ) concentration ranges for prophylactic versus therapeutic use, and the factors influencing individualized dosing in young children remain insufficiently characterized. This retrospective study analyzed the clinical data from pediatric patients (2–17 years) at Peking University People’s Hospital from September 2020 to December 2024. The aim was to define optimal concentration thresholds for prophylaxis and treatment and identify sources of pharmacokinetic variability across age groups to support individualized dosing in children. In the exposure-effect study, VCZ trough concentration (C min ) was significantly correlated with clinical efficacy. VCZ C min ≥0.41 mg/L and C min ≥1.115 mg/L were proven to be significant predictors of prophylactic and therapeutic dosing success, respectively. For pharmacokinetic analysis, patients were stratified into three age groups: Group 1 (2 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VoriconazoleAntifungal AgentsHumansChildChild, PreschoolAdolescentFemaleMaleRetrospective StudiesCytochrome P-450 CYP2C19Age Factors

Stichwörter der Autor:innen

age groupschildrencut off valueinvasive fungal diseasepharmacokineticstherapeutic drug monitoringtrough concentrationvoriconazole

Substanzen

VoriconazoleAntifungal AgentsCytochrome P-450 CYP2C19

Autor:innen und Institutionen

  • Department of Pharmacy, Peking University People's Hospital, Beijing, China.
  • School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China.
  • School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.

ORCID-Profile: Yidan Zhu, Lin Huang

Förderung

  • Beijing Municipal Natural Science Foundation

Zitieren

APA

Zhu, Y., Zhao, J., Chen, J., Gong, Y., Guo, N., Zhao, Y., Li, Y., Bian, J., Song, X., Yao, Y., Luo, X., Zhang, X., & Huang, L. (2026). Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01169-25

Vancouver

Zhu Y, Zhao J, Chen J, Gong Y, Guo N, Zhao Y, et al. Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01169-25

BibTeX
@article{Zhu2026,
  author = {Zhu, Yidan and Zhao, Jinxia and Chen, Jiali and Gong, Yiru and Guo, Nan and Zhao, Yinyu and Li, Yuanyuan and Bian, Jialu and Song, Xuchen and Yao, Yuxuan and Luo, Xingxian and Zhang, Xiaohong and Huang, Lin},
  title = {Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01169-25}
}
Kostenlos starten →